Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...

A significant advancement in the analysis of tumor-derived DNA has been reported by biotechnology firm VolitionRX. The ...

In a landmark decision, the Andhra Pradesh High Court has drawn a firm line against involving children in DNA testing during ...

Explore 40 years of PCR history, from Kary Mullis’s invention story to the rise of digital PCR and how it revolutionized ...

Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive extreme conditions. After scanning huge genetic databases, researchers found ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent.

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...

From the unveiling of a cloud-based computational platform for metabolomics data analysis, to demonstrating the efficacy and safety of therapeutic antibodies using an innovative mouse model, here are ...

US Diagnostics Center (USDC) operates within the relationship DNA testing space, providing services such as paternity and familial relationship analysis through a laboratory testing model designed to ...

Profiling tumor characteristics and outcomes in colorectal cancers (CRC) from carriers of the recessive MUTYH founders (G396D/Y179C) and the low-penetrance APC founder APC-I1307K. This is an ASCO ...